Latest Biotechnology, Pharmaceutical and Healthcare News from EPM Magazine

15:47 EDT 24th March 2018 | BioPortfolio

Here are the most relevant search results for "EPM Magazine" found in our extensive news archives from over 250 global news sources.

More Information about EPM Magazine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about EPM Magazine for you to read. Along with our medical data and news we also list EPM Magazine Clinical Trials, which are updated daily. BioPortfolio also has a large database of EPM Magazine Companies for you to search.

Showing News Articles 1–25 of 630 from EPM Magazine

Friday 23rd March 2018

The top five tweets: From the LoTF to Brexit — what did EPM readers click on this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

USC launches global scientific effort to find next diabetes drug

Researchers from the University of Southern California (USC) have launched a global scientific effort to find the next diabetes drug by creating a comprehensive model of a cell that is central to the disease.

Biotech completes financing round to advance neuromuscular treatments

A financing round worth €38 million has been completed by biotech company, NMD Pharma, to advance the treatments of neuromuscular disorders.

Probi & Cilag sign long-term agreement to develop probiotic product

Swedish bioengineering company, Probi, has signed a long-term agreement with Cilag, which is a member of the Johnson & Johnson family of companies, for the development of a probiotic product.

CMO Leadership Awards recognise Recipharm as winner in six categories

Contract development and manufacturing organisation (CDMO), Recipharm, has been recognised in the CMO Leadership Awards for 2018, organised by Life Science Leader.

Thursday 22nd March 2018

Envigo invests in expansion of surgical facility in response to rising demand

Provider of products and research services, Envigo, has announced it is investing in an expansion of its surgical facility located in Livermore, California, USA, in response to rising demand from West Coast companies.

FDA approved prefilled syringe version of Lucentis for diabetic retinopathy

The US FDA has approved Genetech’s Lucentis (ranibizumab injection) 0.3 mg prefilled syringe as a new administration method for the treatment of all forms of diabetic retinopathy (DR) in patients with diabetic macular oedema

Johnson Matthey & DKSH sign agreement for distribution of catalysts in Japan

An exclusive distribution agreement has been signed by Johnson Matthey and DKSH, involving the distribution of high-technology catalysts in Japan.

Wednesday 21st March 2018

CPhI Japan 2018 expects increased numbers of generic API companies and suppliers say organisers

Event organisers, UBM, have reported that next month’s CPhI Japan 2018 will play host to an increased number of international generic active pharmaceutical ingredient (API) companies and suppliers.

UK’s pharma and biotech support new Health and Social Care Committee report into Brexit

The associations representing the UK’s pharma and biotech industries have announced their support of the recently published findings of the new Health and Social Care Committee report into Brexit.

MHRA grants positive opinion for volanesorsen under EAMS

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive opinion to Akcea Therapeutics’ volanesorsen for the treatment of familial chylomicronaemia syndrome (FCS) under the Early Access to Medicines Scheme (EAMS).

Mallinckrodt reveals winner of inaugural Investigator Award

Mallinckrodt has announced that Dr Nick Matthews and co-investigator Dr Arun Alfred of the Department of Haematology at Rotherham NHS Foundation Trust, UK, are the inaugural recipients of the Advancing ECP Immunomodulation Investigator Award.

Tuesday 20th March 2018

Life sciences industry should collaborate more to build the LoTF, says the Pistoia Alliance

The Pistoia Alliance, a not for profit alliance, has called on the life sciences industry to support the ‘Lab of the Future’ (LoTF) through greater collaboration during its annual EU member conference held in London.

New national standards launch to improve UK public involvement in research

A new set of national standards have been launched at the 2018 Patients First conference and the Involving People Network Annual Meeting 2018 that are designed to improve the quality and consistency of public involvement in research across the UK.

Aptus Clinical to be one of 12 recipients of government funding

Contract CRO, Aptus Clinical, is to be one of 12 partners to receive government funding that will be used to ensure more patients benefit from a new generation of disease-fighting medicines for cancer and non-cancer illnesses

Monday 19th March 2018

Partnership between Mundipharma & Celltrion Healthcare expanded

The Mundipharma network of independent associated companies has expanded its partnership with biopharma company Celltrion Healthcare to now include exclusive distribution rights to trastuzumab biosimilar, Herzuma, in seven EU markets.

Forendo Pharma receives €3 million loan to support development of endometriosis treatment

Forendo Pharma — portfolio company of Karolinska Development — has been granted a €3 million loan from Business Finland to support the development of a novel drug for the treatment of endometriosis.

Lundbeck acquires Prexton and global rights to foliglurax

Lundbeck has signed a definitive agreement to acquire biopharma company, Prexton Therapeutics, obtaining the global rights for foliglurax — a treatment for Parkinson’s that has recently entered clinical Phase II testing.

Friday 16th March 2018

The top five tweets: From regional growth to drug affordability — what excited EPM readers this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

Autolus announces support of NAATTC and iMATCH to facilitate development of advanced therapies

UK-based biopharmaceutical company, Autolus, has announced its participation in the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) and support of the Innovate Manchester Advanced Therapy Centre Hub (iMATCH) consortium.

Partnership formed to accelerate process of taking reference standards to China

Horizon Discovery Group has entered into a partnership with a life sciences company focused on accelerating the standardisation of diagnostic testing in China, Genewell Biotechnology.

Thursday 15th March 2018

Strategic partnership formed to produce US DEA controlled substances

Producer of controlled substances for the pharma industry, Noramco, has entered into a strategic partnership with active pharmaceutical ingredient (API) manufacturer, AMPAC Fine Chemicals (AFC), to produce specific US DEA controlled substances.

Ardena acquires contract manufacturer of APIs and nanomedicines

Ardena, contract development and manufacturing organisation (CDMO), has acquired a contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines, ChemConnection.

Recipharm reveals winner of 2017 International Environmental Award

Contract development and manufacturing organisation (CDMO), Recipharm, has revealed that the winner of its 2017 International Environmental Award is Karen Kidd

Wednesday 14th March 2018

Partnership extended to develop novel anti-cancer drugs targeting MCL1

Boehringer Ingelheim and Vanderbilt University have expanded their partnership to develop novel anti-cancer drugs that inhibit the myeloid cell leukaemia 1 (MCL1) protein, which is highly prevalent in many difficult to treat cancers.

Quick Search


News Quicklinks